Bloated? How a Simple Water Test Can Reveal Hidden Digestive Issues
"New research suggests a water-drinking ultrasound test can help diagnose the root causes of functional dyspepsia and guide more effective treatments."
Functional gastrointestinal disorders, characterized by symptoms like bloating and stomach pain, are a common problem. Often, standard endoscopies reveal no structural abnormalities, leading to a diagnosis of functional dyspepsia (FD). This condition, affecting a significant portion of the population, can negatively impact quality of life and lead to substantial healthcare costs.
Understanding the underlying causes of FD is crucial for developing effective treatments. While various diagnostic tests exist, many lack convenience or have limitations in evaluating gastric functions. Common symptoms include post-meal distress and epigastric pain, with FD patients often experiencing abnormalities in gut function, such as impaired accommodation (the stomach's ability to relax and expand after a meal), delayed emptying, and heightened sensitivity to stimuli.
Now, new research explores the potential of a water-drinking ultrasonography combined test (WDUCT) to assess gastric motility and sensory functions in individuals with FD. This approach offers a non-invasive, accessible method for evaluating stomach function and guiding more targeted treatment strategies.
Bloating’s Burden
Bloating, with or without visible abdominal distension, is often reported by people with irritable bowel syndrome (IBS) and functional dyspepsia (FD). These symptoms may arise through partly different underlying mechanisms. FD can involve epigastric pain or burning, fullness after meals, or early satiety that restricts eating, and often includes bloating and nausea. A review describes FD and bloating as common conditions that can negatively affect quality of life and the health-care system.
How FD Is Diagnosed
Functional dyspepsia is diagnosed when no organic cause is identified to explain the symptoms. The Rome IV criteria define symptom-based diagnosis and distinguish postprandial distress syndrome, associated with post-meal bloating and fullness, from epigastric pain syndrome. One review defines FD as persistent post-meal bloating, early satiety, or central upper-abdominal pain without explanatory findings on upper endoscopy, such as peptic ulcer disease. The condition can remain undiagnosed for years.
A Shifting Definition
The term “functional dyspepsia” was popularized by Walter Alvarez at the Mayo Clinic early in the 20th century. The disorder has long been described as heterogeneous, with multiple possible mechanisms and causal pathways that remain unclear. Rome II defined FD as unexplained epigastric pain or discomfort, though a later historical review noted drawbacks in that definition, including an unjustified focus on particular symptoms. Dyspepsia commonly involves overlapping symptoms, including post-meal fullness, early satiety, epigastric pain, and burning.
The Water Test: Uncovering Hidden Digestive Issues
Researchers in Ukraine conducted a study involving 120 patients diagnosed with FD according to the Rome III criteria and 30 healthy volunteers. All participants underwent a water-drinking ultrasonography combined test (WDUCT). During the test, participants drank 200ml of water every 3 minutes, up to a total of 1000ml, while ultrasound measurements were taken to assess the stomach's response.
- Gastric Accommodation: Measured by the change in the cross-sectional area of the stomach's fundus (upper portion) before and after water intake.
- Gastric Emptying: Evaluated by measuring the cross-sectional area of the fundus 5 and 10 minutes after completing the water intake.
- Visceral Hypersensitivity: Participants rated their pain and discomfort levels during the water-drinking process using a 4-point Likert scale.
Ultrasound and Stomach Function
Reviews report that transabdominal ultrasound, using both two-dimensional and three-dimensional imaging, can identify aspects of functional dyspepsia pathophysiology. In one study, the stomach’s antral area after a test meal was larger in patients with FD than in healthy subjects, a finding that suggested slower gastric emptying. Research using a drinking-ultrasonography combined test also reported abnormalities in gastric emptying and accommodation among FD patients. A separate test-liquid-meal study found that the proximal stomach was significantly smaller in FD patients than in healthy controls.
Two Symptom Patterns
Functional dyspepsia is described as persistent post-meal bloating, early satiety, or pain in the center of the upper abdomen, without upper-endoscopy findings such as peptic ulcer disease to explain the symptoms. The review reports two subtypes: epigastric pain syndrome and postprandial distress syndrome. These patterns distinguish pain-centered symptoms from post-meal distress, although the available source excerpt does not provide further comparative details.
Hope for Targeted Treatments
The study highlights the potential of the WDUCT as a valuable tool for diagnosing gastric motor and sensory dysfunction, particularly in patients with postprandial distress syndrome (PDS) and those with overlapping PDS and epigastric pain syndrome (EPS).
Chronic Symptoms, No Single Fix
Cleveland Clinic describes functional dyspepsia as a kind of chronic indigestion involving frequent stomachaches and fullness or bloating after eating. A healthcare provider may diagnose it when no direct cause for the symptoms can be found. The source notes that several treatment options are available, but no single solution works for everyone.
Research and Quality of Life
A 2026 bibliometric analysis of research on functional dyspepsia overlapping with other functional gastrointestinal disorders ranked Mayo Clinic first among the ten highest-output institutions worldwide. It reported 170 publications and 11,842 total citations for the Mayo Clinic. A 2025 case report on constitution-specific interventions based on ECM assessed dyspepsia-related quality of life alongside symptom improvement and described its findings as preliminary evidence for personalized approaches.
By identifying specific abnormalities in gastric function, the WDUCT could pave the way for more targeted therapies, such as medications that promote gastric accommodation or reduce visceral hypersensitivity. While current treatments for FD have limited effectiveness due to the poorly understood underlying mechanisms, this new diagnostic approach offers a path toward personalized treatment strategies.
The WDUCT is easy to perform, well-tolerated, and readily available in clinical practice, making it a promising tool for improving the diagnosis and management of functional dyspepsia and related digestive disorders.